{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:00:51Z","timestamp":1793462451983,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008451","name":"Binghamton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023583","name":"Office on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023583","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007238","name":"Office of Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xphs.2025.103767","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:53:03Z","timestamp":1742356383000},"page":"103767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Microfluidic blood-milk barrier and physiologically based pharmacokinetic model to predict lofexidine secretion into breast milk"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-8262","authenticated-orcid":false,"given":"Sanat Kumar","family":"Dash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Asikur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0416-2731","authenticated-orcid":false,"given":"Peng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen J.","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-8230","authenticated-orcid":false,"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103767_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apa.13147","article-title":"Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis","volume":"104","author":"Sankar","year":"2015","journal-title":"Acta Paediatr"},{"issue":"S1","key":"10.1016\/j.xphs.2025.103767_bib0002","doi-asserted-by":"crossref","DOI":"10.1089\/bfm.2019.0032","article-title":"Breastfeeding: investing in the future","volume":"14","author":"Horta","year":"2019","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.xphs.2025.103767_bib0003","unstructured":"Horta, B. L., Victora, C. G., & World Health Organization. (2013). Short-term effects of breastfeeding: a systematic review on the benefits of breastfeeding on diarrhoea and pneumonia mortality."},{"key":"10.1016\/j.xphs.2025.103767_bib0004","unstructured":"Bernardo H, Cesar V, & World Health Organization. (2013). Long-term effects of breastfeeding: a systematic review."},{"issue":"153","key":"10.1016\/j.xphs.2025.103767_bib0005","article-title":"Investigation on factors associated with ovarian cancer: an umbrella review of systematic reviews and meta-analyses","volume":"14","author":"Tanha","year":"2021","journal-title":"J Ovarian Res"},{"issue":"12","key":"10.1016\/j.xphs.2025.103767_bib0006","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/annonc\/mdv379","article-title":"Breastfeeding and breast cancer risk by receptor status\u2014a systematic review and meta-analysis","volume":"26","author":"Islami","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.xphs.2025.103767_bib0007","article-title":"Use of medications by breastfeeding women in the 2015 Pelotas (Brazil) birth cohort study","author":"Lutz","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0008","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0890334418775630","article-title":"Medication use during pregnancy and lactation in a Dutch population","volume":"35","author":"de Waard","year":"2018","journal-title":"J Hum Lactat"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0009","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/bfm.2007.0010","article-title":"Extent of medication use in breastfeeding women","volume":"2","author":"Stultz","year":"2007","journal-title":"Breastfeed Med"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.wombi.2017.12.004","article-title":"Why does the need for medication become a barrier to breastfeeding? A narrative review","volume":"31","author":"McClatchey","year":"2018","journal-title":"Women and Birth"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10928-020-09676-2","article-title":"Clinical lactation studies and the role of pharmacokinetic modeling and simulation in predicting drug exposures in breastfed infants","volume":"47","author":"Anderson","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.xphs.2025.103767_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111038","article-title":"A comprehensive review on non-clinical methods to study transfer of medication into breast milk: a contribution from the ConcePTION project","volume":"136","author":"Nauwelaerts","year":"2021","journal-title":"Biomed Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.xphs.2025.103767_bib0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016. MMWR","volume":"67","author":"Seth","year":"2018","journal-title":"Morbid Mortal Weekly Rep"},{"key":"10.1016\/j.xphs.2025.103767_bib0014","series-title":"Problems of Drug Dependence 1981: Proceedings of the 43rd Annual Scientific Meeting, Committee on Problems of Drug Dependence, Inc","first-page":"264","article-title":"Lofexidine blocks acute opiate withdrawal","author":"Annitto","year":"1982"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0376-8716(96)01289-6","article-title":"Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal","volume":"43","author":"Bearn","year":"1996","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.xphs.2025.103767_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002024.pub5","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database System Rev"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.64719\/pb.4615","article-title":"A comprehensive update of lofexidine for the management of opioid withdrawal symptoms","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol Bull"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0018","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/00952990802308122","article-title":"Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis","volume":"34","author":"Yu","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0019","first-page":"241","article-title":"Sedating drugs and breastfeeding","volume":"61","author":"Chow","year":"2015","journal-title":"Canad Fam Physician"},{"issue":"24","key":"10.1016\/j.xphs.2025.103767_bib0020","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"New Engl J Med"},{"issue":"12","key":"10.1016\/j.xphs.2025.103767_bib0021","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus, and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.xphs.2025.103767_bib0022","unstructured":"Center for Drug Evaluation and Research. (2018). Application number: 209229Orig1s000 multi-discipline review summary. Retrieved fromhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/209229Orig1s000MultidisciplineR.pdf"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0023","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/00952990903060135","article-title":"Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patients","volume":"35","author":"Al Ghananeem","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0024","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jps.21401","article-title":"Pharmacokinetics of Lofexidine Hydrochloride in Healthy Volunteers","volume":"98","author":"Al-Ghananeem","year":"2009","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103767_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.beem.2017.10.008","article-title":"Physiology of milk secretion","volume":"31","author":"Truchet","year":"2017","journal-title":"Best Pract Res Clinic Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.xphs.2025.103767_bib0026","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acs.molpharmaceut.2c00193","article-title":"Developing an in vitro to in vivo extrapolation (IVIVE) model to predict human milk-to-plasma drug concentration ratios","volume":"19","author":"Yang","year":"2022","journal-title":"Mol Pharmac"},{"issue":"4","key":"10.1016\/j.xphs.2025.103767_bib0027","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0253-7613.114994","article-title":"Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs","volume":"45","author":"Athavale","year":"2013","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0028","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02968594","article-title":"Development of a human mammary epithelial cell culture model for evaluation of drug transfer into milk","volume":"29","author":"Kimura","year":"2006","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.xphs.2025.103767_bib0029","series-title":"Xenobiotic Transporters in Lactating Mammary Epithelial Cells: Predictions for Drug Accumulation in Breast Milk","author":"Empey","year":"2007"},{"key":"10.1016\/j.xphs.2025.103767_bib0030","article-title":"An in vitro human mammary epithelial cell permeability assay to assess drug secretion into breast milk","volume":"4","author":"Zhang","year":"2022","journal-title":"Int J Pharm X"},{"issue":"21","key":"10.1016\/j.xphs.2025.103767_bib0031","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1039\/C5LC00633C","article-title":"Flow-induced stress on adherent cells in microfluidic devices","volume":"15","author":"Shemesh","year":"2015","journal-title":"Lab Chip"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0032","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0169-409X(03)00033-4","article-title":"Mammary physiology and milk secretion","volume":"55","author":"McManaman","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.103767_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2020.109640","article-title":"Fluid-structure interaction modeling of lactating breast","volume":"103","author":"Azarnoosh","year":"2020","journal-title":"J Biomech"},{"key":"10.1016\/j.xphs.2025.103767_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.694218","article-title":"Engineering Breast Cancer On-chip\u2014Moving Toward Subtype Specific Models","volume":"9","author":"Moccia","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"16","key":"10.1016\/j.xphs.2025.103767_bib0035","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1039\/C5LC00514K","article-title":"A microengineered pathophysiological model of early-stage breast cancer","volume":"15","author":"Choi","year":"2015","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0036","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1038\/s41467-020-17102-x","article-title":"Uncovering mutation-specific morphogenic phenotypes and paracrine-mediated vessel dysfunction in a biomimetic vascularized mammary duct platform","volume":"11","author":"Kutys","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0037","doi-asserted-by":"crossref","first-page":"jcs248849","DOI":"10.1242\/jcs.248849","article-title":"Mammary mechanobiology\u2013investigating roles for mechanically activated ion channels in lactation and involution","volume":"134","author":"Stewart","year":"2021","journal-title":"J Cell Sci"},{"issue":"9","key":"10.1016\/j.xphs.2025.103767_bib0038","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1073\/pnas.0712287105","article-title":"Shear stress regulates aquaporin-5 and airway epithelial barrier function","volume":"105","author":"Sidhaye","year":"2008","journal-title":"Proc Nat Acad Sci"},{"issue":"9","key":"10.1016\/j.xphs.2025.103767_bib0039","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1248\/bpb.b22-00092","article-title":"Intestinal permeability of drugs in caco-2 cells cultured in microfluidic Devices","volume":"45","author":"Sasaki","year":"2022","journal-title":"Biol Pharmac Bull"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0040","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1038\/s41598-021-89288-z","article-title":"Biomechanical regulation of breast cancer metastasis and progression","volume":"11","author":"Spencer","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0041","article-title":"Fluid shear stress induces drug resistance to doxorubicin and paclitaxel in the breast cancer cell line MCF7","volume":"2","author":"Triantafillu","year":"2019","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0042","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40495-020-00212-x","article-title":"Utilization of physiologically based pharmacokinetic modeling in clinical pharmacology and therapeutics: an overview","volume":"6","author":"Perry","year":"2020","journal-title":"Curr Pharmacol Rep"},{"issue":"9","key":"10.1016\/j.xphs.2025.103767_bib0043","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/psp4.12662","article-title":"Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically-based pharmacokinetic model","volume":"10","author":"Abduljalil","year":"2021","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103767_bib0044","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.2335","article-title":"Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk","volume":"43","author":"Zhang","year":"2022","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"10.1016\/j.xphs.2025.103767_bib0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/bdd.2334","article-title":"Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model","volume":"43","author":"Pansari","year":"2022","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.xphs.2025.103767_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051469","article-title":"Generic workflow to predict medicine concentrations in human milk using physiologically-based pharmacokinetic (PBPK) modelling\u2014a contribution from the ConcePTION project","author":"Nauwelaerts","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2025.103767_bib0047","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s11095-022-03274-2","article-title":"Applications, challenges, and outlook for PBPK modeling and simulation: a regulatory, industrial and academic perspective","volume":"39","author":"Lin","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103767_bib0048","first-page":"126","article-title":"Measuring the density and viscosity of culture media for optimized computational fluid dynamics analysis of in vitro devices","author":"Poon","year":"2022","journal-title":"J Mech Behav Biomed Mater"},{"issue":"7","key":"10.1016\/j.xphs.2025.103767_bib0049","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41372-022-01492-5","article-title":"Human milk pH is associated with fortification, postpartum day, and maternal dietary intake in preterm mother-infant dyads","volume":"43","author":"Filatava","year":"2023","journal-title":"J Perinatol"},{"key":"10.1016\/j.xphs.2025.103767_bib0051","series-title":"Encyclopedia of Human Nutrition","article-title":"Breastfeeding","author":"Lutter","year":"2005"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0052","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0163-7258(93)90072-L","article-title":"Modelling of the passage of drugs into milk","volume":"59","author":"Begg","year":"1993","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0053","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0169-409X(03)00032-2","article-title":"Models and methods for predicting drug transfer into human milk","volume":"55","author":"Fleishaker","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.103767_bib0054","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1C379","article-title":"Prediction of milk\/plasma concentration ratio of drugs","author":"Larsen","year":"2003","journal-title":"Annf Pharmacother"},{"issue":"12","key":"10.1016\/j.xphs.2025.103767_bib0055","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1124\/dmd.111.040972","article-title":"Analysis and prediction of drug transfer into human milk taking into consideration secretion and reuptake clearances across the mammary epithelia","volume":"39","author":"Koshimichi","year":"2011","journal-title":"Drug Metabol Disposit"},{"issue":"6","key":"10.1016\/j.xphs.2025.103767_bib0056","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s11095-006-9210-3","article-title":"Mechanistic approaches to volume of distribution predictions: understanding the processes","volume":"24","author":"Rodgers","year":"2007","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0057","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40122-018-0108-7","article-title":"The role of lofexidine in management of opioid withdrawal","volume":"8","author":"Pergolizzi","year":"2019","journal-title":"Pain Therapy"},{"key":"10.1016\/j.xphs.2025.103767_bib0058","first-page":"e4827","article-title":"Clinical efficacy and safety profile of lofexidine hydrochloride in treating opioid withdrawal symptoms: a review of literature","volume":"11","author":"Rehman","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.xphs.2025.103767_bib0059","unstructured":"Lofexidine hydrochloride | DrugBank Online. (n.d.). Accessed 18 November 2023. https:\/\/go.drugbank.com\/salts\/DBSALT000829"},{"key":"10.1016\/j.xphs.2025.103767_bib0060","unstructured":"U.S. Food and Drug Administration (FDA). (2018). Lucemyra (lofexidine) prescribing information. Retrieved from https:\/\/www.accessdata.fda.gov"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0061","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0890334411435414","article-title":"Blood flow characteristics of the human lactating breast","volume":"28","author":"Geddes","year":"2012","journal-title":"J Hum Lactat"},{"issue":"7","key":"10.1016\/j.xphs.2025.103767_bib0062","article-title":"Mathematical modeling of mammary ducts in lactating human females","volume":"137","author":"Mortazavi","year":"2015","journal-title":"J Biomech Eng"},{"issue":"5","key":"10.1016\/j.xphs.2025.103767_bib0063","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1469-7580.2005.00417.x","article-title":"Anatomy of the lactating human breast redefined with ultrasound imaging","volume":"206","author":"Ramsay","year":"2005","journal-title":"J Anat"},{"issue":"10","key":"10.1016\/j.xphs.2025.103767_bib0064","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/pharmaceutics13101563","article-title":"Re-use of Caco-2 monolayers in permeability assays\u2014Validation regarding cell monolayer integrity","volume":"13","author":"Pires","year":"2021","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2025.103767_bib0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jps.2600770916","article-title":"Relationship between human milk lipid-ultrafiltrate and octanol-water partition coefficients","volume":"77","author":"Atkinson","year":"1988","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2025.103767_bib0066","first-page":"392","article-title":"Lofexidine (Lucemyra) for treatment of opioid withdrawal symptoms","volume":"99","author":"Bryce","year":"2019","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0067","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3565(24)36459-6","article-title":"Active transport of nitrofurantoin across a mouse mammary epithelial monolayer","volume":"280","author":"Villi","year":"1997","journal-title":"J Pharmacol Exp Therap"},{"issue":"6","key":"10.1016\/j.xphs.2025.103767_bib0068","first-page":"H1850","article-title":"Acute and chronic exposure to shear stress have opposite effects on endothelial permeability to macromolecules","volume":"298","author":"Warboys","year":"2010","journal-title":"Am J Physiol"},{"key":"10.1016\/j.xphs.2025.103767_bib0069","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00003088-198814040-00003","article-title":"Drugs in human milk: clinical pharmacokinetic considerations","volume":"14","author":"Atkinson","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0070","first-page":"84","article-title":"Placental structure, function and drug transfer. Continuing education in anaesthesia","volume":"15","author":"Griffiths","year":"2015","journal-title":"Critic Care Pain"},{"key":"10.1016\/j.xphs.2025.103767_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116495","article-title":"Systematic review of physiologically based kinetic lactation models for transfer of xenobiotic compounds to milk","volume":"467","author":"Dubbelboer","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103767_bib0072","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/clpt.2008.52","article-title":"Development of translational pharmacokinetic\u2013pharmacodynamic models","volume":"83","author":"Mager","year":"2008","journal-title":"Clinic Pharmacol Therap"},{"issue":"1","key":"10.1016\/j.xphs.2025.103767_bib0073","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"issue":"9","key":"10.1016\/j.xphs.2025.103767_bib0074","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cgh.2017.05.014","article-title":"Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits","volume":"15","author":"Camilleri","year":"2017","journal-title":"Clinic Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103767_bib0075","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1471-4159.2002.01069.x","article-title":"Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics","volume":"82","author":"Miksys","year":"2002","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0076","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clinic Pharmacok"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0077","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0890334408328295","article-title":"Transfer of buprenorphine into breast milk and calculation of infant drug dose","volume":"25","author":"Lindemalm","year":"2009","journal-title":"J Hum Lactat"},{"issue":"2","key":"10.1016\/j.xphs.2025.103767_bib0078","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0890334407300336","article-title":"Concentrations of methadone in breast milk and plasma in the immediate perinatal period","volume":"23","author":"Jansson","year":"2007","journal-title":"J Hum Lactat"},{"issue":"3","key":"10.1016\/j.xphs.2025.103767_bib0079","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/ADM.0000000000000474","article-title":"Safety and efficacy of lofexidine for medically managed opioid withdrawal: a randomized controlled clinical trial","volume":"13","author":"Fishman","year":"2019","journal-title":"J Addict Med"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:31:00Z","timestamp":1762209060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925002254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022354925002254"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103767","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microfluidic blood-milk barrier and physiologically based pharmacokinetic model to predict lofexidine secretion into breast milk","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103767"}}